Primary Contraindications for Midodrine
Midodrine is absolutely contraindicated in patients with severe organic heart disease, acute renal disease, urinary retention, pheochromocytoma, thyrotoxicosis, and persistent/excessive supine hypertension. 1
Absolute Contraindications (FDA Drug Label)
The following conditions represent absolute contraindications where midodrine should NOT be used 1:
- Severe organic heart disease
- Acute renal disease
- Urinary retention
- Pheochromocytoma
- Thyrotoxicosis
- Persistent and excessive supine hypertension
Critical Precautions and Relative Contraindications
Supine Hypertension Risk
Supine hypertension is the most clinically significant concern and occurs in up to 25% of patients. 1, 2 This can manifest as:
- Cardiac awareness or pounding in ears
- Headache
- Blurred vision
Management strategy: Patients must avoid taking the last daily dose within 3-4 hours of bedtime and should sleep with the head of the bed elevated 1. If supine hypertension persists despite these measures, discontinue midodrine immediately 1.
Urinary Retention
Midodrine acts on alpha-adrenergic receptors of the bladder neck, increasing sphincter tone 1. This is particularly dangerous in patients with spinal cord injury who void spontaneously, as it can insidiously cause progressive urinary retention and worsen detrusor-sphincter dyssynergia, potentially leading to hydroureteronephrosis 3. In these patients, if midodrine is essential, intermittent catheterization combined with antimuscarinic therapy should be implemented 3.
Cardiac Considerations
Use with extreme caution when combining with 1:
- Cardiac glycosides (digitalis) - may precipitate bradycardia, AV block, or arrhythmias
- Beta blockers - additive bradycardic effects
- Other agents reducing heart rate - monitor for pulse slowing, increased dizziness, syncope
Renal and Hepatic Impairment
Start with 2.5 mg dosing in renal impairment since desglymidodrine (active metabolite) is renally eliminated 1. Assess renal and hepatic function before initiating therapy 1. Recent data suggests midodrine may be associated with dose-dependent increased mortality in hemodialysis patients 4, warranting particular caution in this population.
Drug Interactions to Avoid
Do not combine with other vasoconstrictors unless absolutely necessary with close blood pressure monitoring 1:
- Phenylephrine
- Pseudoephedrine
- Ephedrine
- Dihydroergotamine
- Droxidopa
- Thyroid hormones
Special Populations
- Diabetic patients with orthostatic hypotension - use cautiously 1
- Patients with visual problems taking fludrocortisone - increased risk of elevated intraocular pressure and glaucoma 1
Common Pitfalls
The most critical error is failing to recognize persistent supine hypertension, which can lead to serious cardiovascular complications. Always instruct patients to report symptoms immediately and implement the 3-4 hour pre-bedtime dosing restriction from the outset 1.
In patients with neurogenic bladder or spinal cord injury, urologic adverse effects develop insidiously and may not be immediately apparent 3. These patients require close urologic monitoring, and midodrine should be discontinued if urinary symptoms emerge.
Avoid the temptation to combine multiple vasoconstrictors without careful blood pressure monitoring, as this significantly increases hypertension risk 1.